NCT03906565 - Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions

Advanced or Metastatic CRC

Interventions

DRUG

utidelone injection

utidelone monotherapy in patients with advanced or metastatic CRC by iv transfusing utidelone injection

Trial Locations (5)

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Harbin Medical University Cancer Hospital, Harbin

Tianjin People's Hospital, Tianjin

Sun Yat-sen University Cancer Center, Guangzhou

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou